These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 18652825

  • 1. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 2. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.
    Law AY, Yeung BH, Ching LY, Wong CK.
    J Cell Biochem; 2011 Aug 01; 112(8):2089-96. PubMed ID: 21465530
    [Abstract] [Full Text] [Related]

  • 3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 01; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 4. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.
    Int J Mol Med; 2008 Nov 01; 22(5):605-11. PubMed ID: 18949380
    [Abstract] [Full Text] [Related]

  • 5. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F, Caby S, Oger F, Cosseau C, Capron M, Grunau C, Dissous C, Pierce RJ.
    Mol Biochem Parasitol; 2009 Nov 12; 168(1):7-15. PubMed ID: 19538992
    [Abstract] [Full Text] [Related]

  • 7. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX, Fang JY, Lu J, Qiu DK.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):312-7. PubMed ID: 15059516
    [Abstract] [Full Text] [Related]

  • 8. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N, Seuter S, Schnur N, Jung M, Steinhilber D.
    Biol Chem; 2003 May 17; 384(5):777-85. PubMed ID: 12817474
    [Abstract] [Full Text] [Related]

  • 9. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U, Renkawitz R, Baniahmad A.
    Anticancer Res; 2000 May 17; 20(2A):1017-22. PubMed ID: 10810390
    [Abstract] [Full Text] [Related]

  • 10. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S, Lu J, Zhang Y, Cheng C, Li L, Han L, Huang B.
    Immunol Lett; 2007 Feb 15; 108(2):143-50. PubMed ID: 17270283
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM, Soeth E, Smith CL.
    Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H, Wu X.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):860-7. PubMed ID: 15474507
    [Abstract] [Full Text] [Related]

  • 13. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH.
    Int J Oncol; 2005 Aug 15; 27(2):473-9. PubMed ID: 16010430
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T.
    Biochem Biophys Res Commun; 1997 Dec 08; 241(1):142-50. PubMed ID: 9405248
    [Abstract] [Full Text] [Related]

  • 16. [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A].
    Li X, Bai XZ.
    Mol Biol (Mosk); 2008 Dec 08; 42(6):990-6. PubMed ID: 19140318
    [Abstract] [Full Text] [Related]

  • 17. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Björkholm M, Henriksson M, Gruber A, Xu D.
    Exp Cell Res; 2002 Mar 10; 274(1):25-34. PubMed ID: 11855854
    [Abstract] [Full Text] [Related]

  • 18. Induction of stanniocalcin-1 expression in apoptotic human nasopharyngeal cancer cells by p53.
    Lai KP, Law AY, Yeung HY, Lee LS, Wagner GF, Wong CK.
    Biochem Biophys Res Commun; 2007 May 18; 356(4):968-75. PubMed ID: 17395153
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan 18; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 20. Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures.
    Vanhaecke T, Henkens T, Kass GE, Rogiers V.
    Biochem Pharmacol; 2004 Aug 15; 68(4):753-60. PubMed ID: 15276083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.